Stockreport

Gilead Sciences Details Tubulis, Ouro, Arcellx Deals as Pipeline Catalyst, 2026 Updates Loom [Yahoo! Finance]

Arcellx, Inc.  (ACLX) 
PDF pipeline across oncology, virology and inflammation, and said it still expects multiple Phase 3 readouts in 2026 and “up to 10” potential launches through 2027 with no m [Read more]